ReviewJournal of clinical and experimental dentistry2025
Oral amelanotic melanoma in a 73-year-old patient: A rare case report and literature review.
Review in Journal of clinical and experimental dentistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral melanoma is an aggressive neoplasm that predominantly affects older adults. The amelanotic subtype is exceedingly rare, and its diagnosis is challenging due to the absence of pigmentation. Herein, we report a rare case of oral amelanotic melanoma in an older adult, discussed in light of the available literature. A 73-year-old Brazilian female patient presented with pain and discomfort in the left transverse palatal rugae. Clinically, the lesion appeared as a single, sessile, dome-shaped nodule with a coloration similar to the adjacent mucosa. Histopathological examination revealed a spindle-cell malignant neoplasm with epithelioid nests within a fibrous stroma, lacking melanin pigmentation. Immunohistochemistry was positive for pan-cytokeratin AE1/AE3, vimentin, S100 protein, Melan-A, SOX10, NSE, and TRP-2, with a high Ki-67 index. The patient died two months after diagnosis. A review of PubMed, Scopus, Embase, and Web of Science identified 35 cases of oral amelanotic melanoma in older adults, predominantly females (n=20/57.1%) in their 60s (n=16/45.7%). This report documents the sixth case of oral amelanotic melanoma in older adults from Latin America. Clinically, the case was challenging because it mimicked a non-neoplastic proliferative process and, microscopically, presented as an amelanotic variant. An immunohistochemical panel is recommended to avoid diagnostic pitfalls; this is the first report of TRP-2 immunoexpression in oral amelanotic melanoma.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.